{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "10025472", "DateCompleted": {"Year": "1999", "Month": "03", "Day": "01"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0002-9262", "JournalIssue": {"Volume": "149", "Issue": "4", "PubDate": {"Year": "1999", "Month": "Feb", "Day": "15"}}, "Title": "American journal of epidemiology", "ISOAbbreviation": "Am J Epidemiol"}, "ArticleTitle": "Double-blind intervention trial on modulation of ozone effects on pulmonary function by antioxidant supplements.", "Pagination": {"StartPage": "306", "EndPage": "314", "MedlinePgn": "306-14"}, "Abstract": {"AbstractText": ["The aim of this study was to investigate whether the acute effects of ozone on lung function could be modulated by antioxidant vitamin supplementation in a placebo-controlled study. Lung function was measured in Dutch bicyclists (n = 38) before and after each training session on a number of occasions (n = 380) during the summer of 1996. The vitamin group (n = 20) received 100 mg of vitamin E and 500 mg of vitamin C daily for 15 weeks. The average ozone concentration during exercise was 77 microg/m3 (range, 14-186 microg/m3). After exclusion of subjects with insufficient compliance from the analysis, a difference in ozone exposure of 100 microg/m3 decreased forced expiratory volume in 1 second (FEV1) 95 ml (95% confidence interval (CI) -265 to -53) in the placebo group and 1 ml (95% CI -94 to 132) in the vitamin group; for forced vital capacity, the change was -125 ml (95% CI -384 to -36) in the placebo group and -42 ml (95% CI -130 to 35) in the vitamin group. The differences in ozone effect on lung function between the groups were statistically significant. The results suggest that supplementation with the antioxidant vitamins C and E confers partial protection against the acute effects of ozone on FEV1 and forced vital capacity in cyclists."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Sciences, Wageningen Agricultural University, The Netherlands."}], "Identifier": [], "LastName": "Grievink", "ForeName": "L", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zijlstra", "ForeName": "A G", "Initials": "AG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ke", "ForeName": "X", "Initials": "X"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Brunekreef", "ForeName": "B", "Initials": "B"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Epidemiol", "NlmUniqueID": "7910653", "ISSNLinking": "0002-9262"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "1406-18-4", "NameOfSubstance": "Vitamin E"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "PQ6CK8PD0R", "NameOfSubstance": "Ascorbic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Air Pollutants"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ascorbic Acid"}, {"QualifierName": [], "DescriptorName": "Bicycling"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Forced Expiratory Volume"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lung Volume Measurements"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Netherlands"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Spirometry"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vital Capacity"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vitamin E"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "2", "Day": "20"}, {"Year": "1999", "Month": "2", "Day": "20", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "2", "Day": "20", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10025472", "10.1093/oxfordjournals.aje.a009814"]}}], "PubmedBookArticle": []}